Home Transfusion for HEME

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 18, 2024

Primary Completion Date

May 13, 2025

Study Completion Date

May 21, 2025

Conditions
Hematologic Malignancy
Interventions
OTHER

Home Transfusion Program Components

The Home Transfusion Program will include trained transfusion nurse(s) who will administer transfusions in the home setting. The transfusion nurse, who is part of the study team, will work closely with the DFCI/BWH Blood Bank and the hospice agency (Care Dimensions Inc.) that all study patients are enrolled in. The transfusion nurse will administer home transfusions using safe home transfusion practices endorsed by the AABB. The home transfusion program has 4 key aspects Initial home visit, (2) subsequent contact, (3) home transfusion assessment \& administration, (4) usual elements of hospice

Trial Locations (1)

02215

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
lead

Dana-Farber Cancer Institute

OTHER

NCT05509439 - Home Transfusion for HEME | Biotech Hunter | Biotech Hunter